CJC-1295 – With DAC 5mg

Researchers investigate CJC-1295 with DAC peptide within controlled laboratory environments to examine modified peptide structures and stability mechanisms. Experimental models utilize this compound to study Drug Affinity Complex conjugation effects in vitro. Controlled laboratory peptide stability studies assess compound properties under standardized experimental conditions. Scientists explore structural modifications and extended stability characteristics in research settings. Laboratory personnel examine modified peptide behavior in experimental models designed for peptide modification research. These investigations occur exclusively in controlled research environments without clinical applications.

CJC-1295 with DAC is investigated in research environments to understand peptide modification mechanisms. This compound is studied within controlled laboratory models examining modified peptide properties. Researchers explore this peptide for experimental peptide research applications in academic and institutional settings. Laboratory studies examine the compound’s stability characteristics under standardized protocols. Scientists investigate structural properties relevant to peptide modification research methodologies. All research applications remain confined to laboratory environments and experimental frameworks.

Store CJC-1295 with DAC peptide in cool, dry conditions protected from light exposure. Storage temperature should remain consistent to maintain compound stability. Keep the product sealed until ready for laboratory use. Laboratory handling should occur only by qualified research personnel trained in peptide research protocols. Avoid exposure to moisture, heat, and direct sunlight during storage. Use appropriate laboratory equipment when handling this research compound. Reconstitution should follow standard laboratory peptide preparation procedures using sterile techniques. Maintain proper documentation of handling and storage conditions for research records. Dispose of unused material according to institutional laboratory waste protocols.

Each batch undergoes comprehensive purity verification procedures to confirm research-grade quality. Third-party testing validates compound purity at 99%+ by HPLC analysis. Batch-to-batch consistency ensures reliable results across research protocols. Certificate of Analysis accompanies each order documenting purity verification results. Internal quality assurance standards maintain strict compound specifications. Testing procedures verify molecular weight, purity percentage, DAC conjugation, and compound identity. Research-grade supply positioning ensures suitability for controlled laboratory investigations. Quality control documentation supports institutional research compliance requirements.

• CAS: 863288-34-0
• Chemical Formula: C₁₅₂H₂₅₂N₄₄O₄₂
• Molecular Weight: 3648.4 g/mol
• Peptide Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Malimide-beta-Ala)-NH2
• Synonyms: CJC1295, CJC-1295 with DAC
• Shelf life: 24 months from the manufacturing date.

CJC-1295 with DAC is a synthetic modified peptide compound produced for research applications. This peptide is a modified version of a growth hormone-releasing hormone analog. An analog is a molecular structure similar to a natural compound but with specific alterations. The Drug Affinity Complex is a chemical modification attached to the peptide structure. This modification changes how the peptide behaves in experimental test systems. The DAC conjugation provides researchers with a model for studying peptide modifications. This synthetic peptide origin ensures batch-to-batch consistency for research protocols. The compound consists of a defined amino acid sequence with the DAC modification. Researchers examine this modified peptide’s properties within controlled laboratory conditions without therapeutic context.

This synthetic research peptide formulation provides laboratories with a modified GHRH analog compound for experimental studies. The compact 5mg format supports controlled research applications in qualified laboratory settings. Each batch undergoes rigorous purity verification to ensure consistency across research protocols. High-purity formulation meets research-grade standards for modified peptide investigations. Secure packaging protects compound integrity during storage and transport. Discreet shipment ensures confidential delivery to research facilities and institutional laboratories.

The Drug Affinity Complex modification provides a molecular model for studying how chemical conjugations affect peptide properties in experimental systems. The DAC attachment changes the peptide’s physical and chemical characteristics in laboratory test conditions. Researchers use this to investigate peptide modification effects and stability mechanisms in controlled studies.

Research applications include peptide modification studies, stability characterization, conjugation chemistry investigations, and comparative analyses between modified and unmodified peptides. The specific applications depend on research objectives and experimental design. Research teams determine protocols based on their investigation goals.

? Quality control testing confirms the presence and integrity of the DAC modification through analytical methods including HPLC analysis and molecular weight verification. Certificate of Analysis documentation includes conjugation-specific data. Testing ensures the modification is present and properly attached according to research-grade specifications.